Ep187: Eric Fischer on Creating a New Class of Medicines
The Long Run with Luke Timmerman
00:00
Spinning out companies and Neomorph
Luke asks about spinouts; Eric explains company formation, Neomorph’s focus on molecular glues, and partner collaborations.
Transcript
Play full episode
